[HTML][HTML] Circulating tumour cells for early detection of clinically relevant cancer

R Lawrence, M Watters, CR Davies, K Pantel… - Nature Reviews Clinical …, 2023 - nature.com
Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early
detection are paramount to reducing cancer-related deaths and improving patient outcomes …

The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of pathology & …, 2021 - meridian.allenpress.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology

JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

AU Kishan, Y Sun, H Hartman, TM Pisansky… - The lancet …, 2022 - thelancet.com
Background Randomised trials have investigated various androgen deprivation therapy
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …

Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options

MG Sanda, JA Cadeddu, E Kirkby, RC Chen… - The Journal of …, 2018 - auajournals.org
Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …

The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and …

JI Epstein, L Egevad, MB Amin… - The American journal …, 2016 - journals.lww.com
Abstract In November, 2014, 65 prostate cancer pathology experts, along with 17 clinicians
including urologists, radiation oncologists, and medical oncologists from 19 different …

[HTML][HTML] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Parker, E Castro, K Fizazi, A Heidenreich… - Annals of …, 2020 - annalsofoncology.org
Subclinical prostate cancer is common in men> 50 years. Population-based screening of
men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been …

Prostate cancer, version 1.2016

JL Mohler, AJ Armstrong, RR Bahnson… - Journal of the National …, 2016 - jnccn.org
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an
initial diagnosis of prostate cancer and management options for localized, regional, and …

Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer

AU Kishan, A Dang, AJ Katz, CA Mantz… - JAMA network …, 2019 - jamanetwork.com
Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …

Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological …

JI Epstein, MB Amin, VE Reuter… - The American journal of …, 2017 - journals.lww.com
The primary proceedings of the 2014 International Society of Urological Pathology Grading
Conference were published promptly in 2015 and dealt with:(1) definition of various grading …